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Abstract
Introduction: Currently, the United States (U.S.) recommends that infants born to women living with HIV (WLHIV) be fed for-
mula, whereas many low-resource settings follow the World Health Organization’s recommendation to exclusively breastfeed
with ongoing antiretroviral therapy. Evidence on infant feeding among WLHIV in high-resource countries suggest that these
contrasting recommendations create challenges for providers and patients. Our study used multiple methods to understand
providers’ infant feeding perspectives on caring for their pregnant and post-partum WLHIV in the U.S.
Methods: We sent a survey (n = 93) to providers across the U.S. who have cared for WLHIV. A subset of survey participants
opted into a follow-up qualitative interview (n = 21). These methods allowed us to capture a broad understanding of provider
attitudes via the survey and more nuanced qualitative interviews. The study was completed prior to an updated breastfeeding
section of the U.S. Perinatal Guidelines.
Results: The majority of providers (66.7%) discussed infant feeding intent with their patients using open-ended questions.
Many also discussed alternative feeding methods (37.6%) and disclosure avoidance strategies (34.4%). Over 75% (95% confi-
dence interval (CI): 65.1 to 84.2) of participants reported that a WLHIV asked if she could breastfeed her child, and 29%
(95% CI 20 to 40.3) reported caring for a patient who breastfed despite recommendations against breastfeeding. Providers
reported that their patients’ primary concern was stigma associated with not breastfeeding (58%), while providers were pri-
marily concerned about medication adherence during breastfeeding (70%). Through qualitative analysis, four overarching cate-
gories emerged that reflect providers’ sentiments, including (1) U.S. guidelines inadequately addressing WLHIV’s desire to
breastfeed; (2) negotiating patient autonomy amidst complex feeding situations; (3) harm reduction approaches to supporting
WLHIV in breastfeeding; and (4) providers anticipating multilayered patient stigmatization.
Conclusions: The majority of provider respondents cared for a WLHIV who desired to breastfeed, and a third had WLHIV
who breastfed despite recommendations against it. Providers found that the status of U.S. guidelines and their incongruity
with WHO guidelines left them without adequate resources to support WLHIV’s infant feeding decisions. Our findings provide
important insight to inform professional associations’ discussions about public health policy as they consider future directions
for infant feeding guidelines among WLHIV.
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1 | INTRODUCTION
The American Academy of Pediatrics and the United States
(U.S.) Department of Health and Human Services currently
recommend women living with HIV (WLHIV) in the U.S. to
exclusively formula feed their infants due to the risk of HIV
transmission through breast milk [1-3]. Several studies from
low-resource settings demonstrate low rates of HIV transmis-
sion (0% to 3%) with antiretroviral therapy (ART) use before
and during breastfeeding [4-13]. In these low-resource set-
tings where diarrhoeal diseases, pneumonia and malnutrition
are common, access to clean water may be limited and infant
formula may be expensive or inaccessible, the World Health
Organization (WHO) recommends exclusive breastfeeding for
six months and continued breastfeeding up to 24 months with
ongoing ART use by mother and infant [14]. In these settings,
breastfeeding decreases risks of infant morbidity and mortal-
ity [15,16].
The contrast in recommendations between low-resource
and high-resource settings has created challenges for provi-
ders and patients in the U.S. and other high-resource settings
[17-24]. Indeed, in these high-resource settings, national public
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health organizations promote exclusive breastfeeding and con-
tinued breastfeeding up to two years among women who are
HIV negative. Although there is limited research from high-
resource settings, investigating perceptions of infant feeding
among WLHIV, three qualitative studies (one from the United
Kingdom [20] and two from Canada [22,23]) illustrate common
sentiments. WLHIV reported feeling like they were not fulfill-
ing their role as mothers [20,23]. Many women perceived they
were disclosing their HIV status by formula feeding given they
were often asked by friends, family and community members
why they were not breastfeeding. In addition, women felt guilt,
shame and stigma for not being able to breastfeed their
infants, in addition to practical difficulties such as affording,
procuring and preparing infant formula [20].
Consequently, stakeholders within the field of prevention of
mother to child transmission of HIV, including researchers,
providers and patients, have raised questions over the ethics
of maintaining disparate guidelines, warning that this may hin-
der patient–provider communication and overlook the experi-
ences of their patients who have immigrated to the U.S.
[21,22]. Levison et al. further suggest that WLHIV in the U.S.
may desire to breastfeed because of the emotional, cultural
and/or nutritional benefits of breastfeeding, and they suggest
a harm reduction approach for counselling these women [24].
Recently, the British Perinatal Guidelines and U.S. Perinatal
Guidelines contained updates that offer a new section provid-
ing some guidance for providers with patients who wish to
breastfeed [3,25]. Importantly, the updated guidelines con-
tinue to endorse exclusive formula feeding and emphasize
their recommendation to avoid breastfeeding. However, in the
event that a WLHIV has received extensive counselling and
plans to breastfeed, a harm reduction approach is recom-
mended. This strategy includes recommendations for HIV
treatment and adherence monitoring, breastfeeding duration
and weaning, and HIV treatment prophylaxis recommenda-
tions for infants. Although these recommendations provide
official guidance for providers, gaps remain.
Providers are encountering these infant feeding dilemmas
more often in their practices; however, there is insufficient
evidence on their perspectives and current experiences. To fill
these gaps, our study employed a multiple methods approach
to better understand U.S. providers’ attitudes towards and
experiences of caring for WLHIV, and how they navigate their
patients’ infant feeding expectations.
2 | METHODS
An online survey was created that included two sections:
twenty-eight closed-ended items and eight open-ended ques-
tions. It was pilot tested among 10 providers. The survey
asked questions regarding attitudes towards infant feeding
and counselling approaches – both in general and specifically
for WLHIV (see Tables 1 and 2). The anonymous survey was
emailed weekly for one month in 2016 to providers who sub-
scribed to a reproductive infectious disease listserv. The list-
serv had 367 active provider email addresses from several
countries. The listserv is an international forum to connect
clinicians and non-clinicians caring for perinatal WLHIV to dis-
cuss difficult cases, share tools, protocols, ask questions. Only
U.S. providers were asked to participate. Participants who
completed the survey could then opt in to doing a semi-struc-
tured interview.
ET and CT conducted semi-structured interviews with par-
ticipants either in person or by phone. Interviews were
recorded, transcribed and ranged from 22 to 61 minutes (me-
dian 38 minutes). Interview content related to providers’
approaches to counselling WLHIV about infant feeding, their
knowledge of and attitude towards national and international
infant feeding guidelines, and concerns they or their patients
had (if any) around HIV and infant feeding. Data collection for
the survey and qualitative interviews occurred between
September 2016 through April 2017.
An institutional review board approval was granted at Johns
Hopkins University and the University of California San Fran-
cisco. The completion of the survey served as consent, and an
oral consent process was obtained for the semi-structured
interview. Interviewed participants were offered a $25 elec-
tronic Amazon gift card for their time.
3 | DATA ANALYSIS
3.1 | Survey
Demographic data, practice characteristics and closed-ended
survey responses were summarized. Percentages with 95%
confidence intervals (CIs) were calculated. A chi-squared or
Fisher’s exact test was performed to compare categorical
data. Some survey questions included a write-in option when
“other” was selected as a response. These responses were
included verbatim in quotations. STATA (College Station, Texas
version 15) was used.
3.2 | Qualitative semi-structured interviews
We followed a qualitative content analysis approach [26] to sys-
tematically code and classify the data into categories. Tran-
scripts were entered and coded in Dedoose (version 7.6.21).
We began with emergent coding and segmentation of a random
selection of one third of the data (seven transcripts). The basic
unit of analysis was segments of the providers’ descriptions of
their experiences with and/or responses to WLHIV breastfeed-
ing, including opportunities and challenges they have encoun-
tered. We then considered the appropriateness and reliability
of the emerging codes and developed a preliminary codebook
before resuming inductive coding of the remaining transcripts.
Frequent codes, and codes with high rates of co-occurrence,
were exported to Word for closer analysis and conceptual data
clustering. These included initial clusters such as “reducing
harm,” “coordinating care” and “stigma/disclosure”. Using sub-
sumption and progressive summarizing [27], the team began
classifying clusters into broad categories. These categories and
subcategories were then depicted as dendrograms.
4 | RESULTS
4.1 | Quantitative survey
One hundred and eight providers began the survey; 15 were
excluded because they lived outside the U.S. or did not provide
care to WLHIV or their children. A total of 93 respondents
were eligible for inclusion in analysis. The majority of
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respondents were non-Hispanic White women (Table 1). Over
two-thirds practised in an academic setting. Obstetrics/
gynecology (OB/GYN) was the most common specialty (45.1%),
followed by adult medicine (e.g. infectious diseases, HIV medi-
cine, primary care; 38.7%) and pediatric medicine (16.1%).
The majority of providers (66.7%) reported discussing infant
feeding intention with their patients using open-ended ques-
tions (Table 2). Many also discussed alternative feeding meth-
ods (37.6%) and strategies to avoid disclosure of their HIV
status by giving the appearance of breastfeeding (34.4%).
Some providers (21.5%) offered additional counselling and
support to assist WLHIV with breastfeeding, while 16.1%
reported telling WLHIV that they cannot breastfeed without
further discussion. Over 75% (95% CI: 65.1 to 84.2) reported
that a WLHIV asked if she could breastfeed her child, and
29% (95% CI: 20 to 40.3) reported caring for a WLHIV
patient who breastfed despite receiving recommendations to
not breastfeed. Providers reported that approximately half of
those WLHIV who asked to breastfeed and who breastfed
despite recommendations were immigrants. From the provider
perspective, the most frequently cited concerns of their
patients included stigma from family or their community from
not breastfeeding (58%) and not reaping the health benefits
of breastfeeding for their infants (50.5%). The most frequently
cited concerns of providers included medication non-adher-
ence (70%) and the ongoing risk of mother-to-child HIV trans-
mission with breastfeeding (65.6%).
4.2 | Qualitative interviews
Of the 93 survey participants, 21 (23%) completed the
optional semi-structured interview. Participants in the semi-
structured interview included two pediatricians; six OB/GYN
physicians, nurses and midwives; two social workers; one
nurse practitioner, one infectious disease specialist and one
HIV/family practice specialist. Of the remaining eight
Table 1. Demographics and employment characteristics of survey participants by responsea
Total (N = 93) Would not offer BF
Would offer BF or
uncertain p-value
Age category (years)b
<40 34 (37) 2 (13.3) 26 (40.6) 0.06
40 to 49 26 (28.3) 4 (26.7) 19 (29.7)
≥50 32 (34.8) 9 (60) 19 (29.7)
Race/ethnicity
Non-Hispanic White 61 (65.6) 10 (66.7) 42 (33.3) 0.50
Non-Hispanic non-White 26 (28) 5 (33.3) 17 (26.6)
Mixed race 6 (6.5) 0 (0) 5 (7.8)
Sex
Female 82 (88.2) 11 (73.3) 57 (89.1) 0.11
Male 11 (11.8) 4 (26.7) 7 (10.9)
Professional degree
MD 64 (68.8) 14 (93.3) 42 (65.6) 0.21
Advanced practice provider 25 (26.9) 1 (6.7) 19 (29.7)
Social work 2 (2.2) 0 (0) 2 (3.1)
Registered nurse 2 (2.2) 0 (0) 1 (1.6)
Years in practice, median (IQR) 12 (5 to 23) 21 (10 to 26) 12 (4 to 20.5) 0.04
Practice setting 0.52
Academic 64 (68.8) 11 (73.3) 48 (75)
Community 24 (25.8) 3 (20) 15 (23.4)
Government or other 5 (5.4) 1 (6.7) 1 (1.6)
Clinical role
OB/GYN 42 (45.1) 7 (46.7) 27 (42.1) 0.81
Adult infectious diseases or primary care 36 (38.7) 5 (33.3) 27 (42.1)
Paediatric infectious diseases or primary care 15 (16.1) 3 (20) 10 (15.6)
U.S. Location
North-east 20 (21.5) 4 (26.7) 12 (18.8) 0.74
Midwest 12 (12.9) 1 (6.7) 10 (15.6)
South-east 33 (35.5) 6 (40) 22 (34.4)
West 28 (30.1) 4 (26.7) 20 (31.3)
BF: breastfeeding; IQR: interquartile range. aSurvey Question: In African clinical trials, the risk of mother to child transmission is less than 2% with
infant HIV prophylaxis and an undetectable viral load in mothers taking highly active antiretroviral medication. If the patient was willing to accept
the risk, would you consider offering breastfeeding as an option? Reponses are n(%) unless otherwise stated; bage is missing one response.
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Table 2. Responses to survey questionsa
Providers’ approach to counselling N = 93
When you bring up the topic of breastfeeding in women living with HIV do you: n (%)
Acknowledge the recommendation against breastfeeding, but begin an open-ended discussion with patients to find out more
about their desires to breastfeed
62 (66.7)
Discuss alternatives to formula feeding with your patients (e.g. using banked human breast milk) 35 (37.6)
Discuss options that might give the appearance of breastfeeding if your patients are concerned that not being able to
breastfeed will reveal their HIV status
32 (34.4)
Provide counselling and support to assist women living with HIV with breastfeeding 20 (21.5)
Tell women living with HIV that they cannot breastfeed without further discussion 15 (16.1)
Open-ended responses
“I recommend against breastfeeding, but do engage them in conversation about it.”
“Will work with a woman if she is determined to breastfeed”
“I acknowledge the issue of post-partum feeding and that breast feeding is not encouraged due to HIV transmission risk to the baby.”
“Discuss the possible risk of breast feeding and supplemental formula feeding on infant transmission risk”
“Discuss challenges regarding outside caregivers or breast problems; infant bonding techniques without breastfeeding”
“Explain risk with breastfeeding, review bottle feeding”
“I don’t discuss BF as an equal alternative to formula, but do review the rationale/context”
“Tell her in this country because of access to clean water, formula feeding is recommended, but acknowledge that women in Africa on ART do breastfeed.
Also that chances of transmission are hugest for inexperienced first time nursing moms. This was to an African woman who had migrated here and had
breast fed all her other kids. I was not sure what she would do once she delivered, as I felt she may decide to breastfeed despite the U.S.
recommendations and wanted her to have the full information. She was suppressed and the chances of transmission were likely extremely low, especially
past the first day or two. If she had chosen to breast feed I would have supported her. She chose not to. Told her housemates that her doctor had told
her a medicine the doctor gave meant she could not breast feed and they accepted that.”
“Provide options and resources!”
“Explain recommendation and current understanding about [viral load] in breast milk and encourage options and troubleshoot cultural attitudes and expectations”
Patients’ concerns about not breastfeeding
What concerns do your patients living with HIV raise about not being able to breastfeed?
Not being able to reap the health benefits of breastfeeding for mother and/or infant 47 (50.5)
Cost of formula feeding 13 (14)
Stigma associated with not breastfeeding with family/community 54 (58.1)
Stigma associated with formula feeding in society 15 (16.1)
Physical discomfort of breast engorgement 9 (9.7)
Not being able to bond with their child through breastfeeding 35 (37.6)
None of these 4 (4.3)
Open-ended responses:
“They always seem to already know it is not recommended”
Providers’ concerns about supporting breastfeeding
What concerns do you have about supporting your HIV positive patients in breastfeeding?
The ongoing risk of mother to child transmission 61 (65.6)
Concern for non-compliance with ARV and/or extended infant prophylaxis 65 (70)
Concern for side effects of extended infant prophylaxis 32 (34.4)
Legal risks associated with potential transmission 21 (22.6)
Open-ended responses:
“Mixed breast + bottle feeding”
“The legal concern is something that I don’t think should enter one’s decision, when one is going right by the patient based on the available data. It would
be nice to have back up in some kind of statement from a society/guideline group, more to appease horrified colleagues.”
“Discordance of viral load in other compartments such as breastmilk. The small risk of transmission when there are very safe alternatives in the US for
infant feeding which is not the case internationally.”
“Difficulty for mother to manage infant prophylaxis”
Type of support needed to support breastfeeding
What mechanisms would have to be in place for you to assist your HIV positive patients with a consistently undetectable
viral load with breastfeeding?
None. I probably would never assist an HIV positive mother with breastfeeding 7 (7.5)
Clinical guidelines (i.e. government) 58 (62.4)
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participants, seven were physicians who did not specify their
clinical specialty. Participants had varying degrees of clinical
experience working with mothers living with HIV, ranging from
only a few such patients to the majority of their practice. Par-
ticipants covered 11 states across all regions of the U.S. Two-
thirds of participants worked in an academic setting at the
time of the interview, and the remaining third worked in a
community setting. About two-thirds of participants were over
40 years old, and 70% were female.
Four main qualitative categories emerged (Box 1), including
(1) perception of U.S. guidelines as inadequately addressing
WLHIV’s desire to breastfeed; (2) providers negotiating patient
autonomy amidst complex feeding situations; (3) harm reduc-
tion approaches for supporting WLHIV in breastfeeding; and
(4) providers anticipating multilayered patient stigmatization.
4.3 | Category 1: Perception of U.S. guidelines as
inadequately addressing WLHIV’s desire to
breastfeed
Of note, the study was done prior to the update in the U.S.
Perinatal Guidelines. Many providers acknowledged that cur-
rent U.S. guidelines were inadequate in circumstances where
their patients desired to breastfeed. While some providers
adhered to what they believed were insufficient guidelines,
others described developing provisional protocols to handle
requests to breastfeed. Some considered other HIV risk sce-
narios, such as embracing pre-exposure prophylaxis or vaginal
delivery, to rationalize a more proactive approach to support-
ing WLHIV to breastfeed.
Providers also recognized the paradox of divergent guideli-
nes in globalized societies and expressed frustration that
these discrepant guidelines did not meet patients’ needs.
Many were aware of studies in low-resource countries that
indicated low rates of HIV transmission with exclusive breast-
feeding, and often their patients who had emigrated from
these countries had personal experience with distinct feeding
recommendations in their home countries. These patients’
lives spanned multiple continents, and many were uncertain
whether they would return post-partum to their home coun-
tries, posing a dilemma for infant feeding decisions.
4.4 | Category 2: Negotiating patient autonomy
amidst complex feeding situations
A second content category involved providers negotiating
patient autonomy within complex feeding situations. Providers
described a range of patient discomfort with the zero-breast-
feeding guideline and/or ability to follow it. This meant they
had to assess patients’ stated priorities alongside their psy-
chological wellbeing and potential structural barriers to for-
mula feeding. While some providers served populations for
which formula feeding was common practice, many encoun-
tered situations requiring more detailed discussion of feeding
practices. Interviews revealed a continuum wherein a few pro-
viders described taking a firm lead to guide patients towards
formula feeding, while many others prioritized patients’ auton-
omy. Providers also reported that while some patients wanted
them to make the risk-benefit calculations on their behalf,
others (particularly immigrant patients or U.S.-born, English-
speaking mothers who had lived with HIV for many years)
stressed the benefits of breastfeeding despite receiving rec-
ommendations from health professionals to formula feed.
Even among mothers who agreed to forgo breastfeeding,
providers identified psychological and structural challenges
around formula feeding that required careful negotiation. This
was particularly true in cases of immigrant mothers. Some
providers expressed concern that prohibiting a patient from
breastfeeding would lead to psychological distress, whether by
impeding a mother’s cultural norms or her sense of bonding
with her infant. Other providers stressed more structural con-
cerns related to formula feeding. For instance, navigating
Woman, Infants and Children (WIC) benefits and accessing
formula feeding education and support was challenging for
women who were unfamiliar with formula feeding and/or
using bottles. Thus, mothers who follow U.S. guidelines by
deciding not to breastfeed may also require ongoing psycho-
logical and social support to carry out that decision.
Table 2. (Continued)
Committee opinion developed by a national organization (i.e. ACOG, AAP, IAS) 59 (63.4)
Legal protection 25 (26.9)
Clinical data on benefits 48 (51.6)
Open-ended responses:
“If they decide to breastfeed that is their prerogative and I would assist them despite disagreeing with them”
“Patient preference”
“Only if living in resource poor country”
“Data on real world practice (not just from clinical trials where there is a specific program for providing access to care and long term monitoring with a lot
of resources of study personnel and study funds.”
“Team approach with a supportive pediatrician”
“We developed a detailed counseling guide which we review with mom and ask her to sign acknowledging risk and understanding. We then place infant on
ARV throughout breastfeeding, monitor mother and infant monthly for HIV viral load and ARV toxicity, and advocate for rapid weaning. It has been very
stressful on clinicians and mothers alike, and lots of work.”
“Data that the benefits of breastfeeding really do outweigh the transmission risk.”
“Again would try to prevent breastfeeding in US as I believe it medically wrong to expose the baby to any risk of HIV transmission where none exists.”
“The more of these that are in place, the easier to convince providers to be more permissive with patients.”
ART, antiretroviral therapy. aParticipants could select more than one answer
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4.5 | Category 3: Harm reduction approaches for
supporting WLHIV in breastfeeding
Harm reduction emerged as a common strategy among sev-
eral providers when facing infant feeding dilemmas, which is
illustrated in Figure 1. While few providers promoted develop-
ing their own protocols that differed from governing bodies’
recommendations, most providers acknowledged that if a
WLHIV was determined to breastfeed, they needed to help
minimize risks. These providers recounted various approaches
to reducing harm in such situations, including coordinating
care across health providers and systems, addressing
resistance within the care team and ensuring ongoing viral
suppression.
Ensuring the success of harm reduction meant mobilizing
the entire team, including providers within obstetrics, pedia-
trics and social work to agree on a shared care plan. This
helped to avoid escalations such as reporting breastfeeding
events to child protection agencies. Other harm reduction
strategies included practitioners seeking out information about
the context in which women would be executing infant feeding
plans, including whether a woman planned to stay in the U.S.
or attitudes within communities on infant feeding behaviours.
For example, WLHIV returning to their home countries might
Box 1. Illustrative Quotes from the Qualitative Semi-structured Interviews
Category 1: Perception of U.S. guidelines as inadequately addressing WLHIV’s desire to breastfeed
. . .it’s becoming more clear that you can’t just say . . . this continent breastfeeds, these other continents don’t breastfeed. Physi-
cian
It’s this irrational, surreal thing. . . that women, when they hit the ground in Liberia, they’re supposed to start breastfeeding, but
while they’re here [in the U.S.], they’re not. Pediatric HIV specialist
I recently came back from Malawi, they kind of roll their eyes when I tell them this is even an issue in the U.S. because there,
exclusive breastfeeding, it’s the norm and that’s the standard of care. Obstetrician
Category 2: Negotiating patient autonomy amidst complex feeding situations
I tell the patients at the beginning that they have to have some trust that I will do the best for them and for the infant. . . .
They asked me to fly this plane for them. Obstetrician
[Patients] are coming to these questions based on just the fact that they’re living for a long time, and they’re taking meds, and
the meds are working, and so why wouldn’t breastfeeding be an option? Nurse practitioner
I always acknowledge with women how hard it is, if you want to breastfeed, not to breastfeed. Midwife
I did feel badly because if really the risks are extremely low and the person is suffering in some way mentally, psychologically
by not [breastfeeding]. . . Physician
Category 3: Harm reduction approaches for supporting WLHIV in breastfeeding
. . . the main concern would be that a mother would choose to do this and not feel like she could talk to her provider about it,
so then there’d be no way of actually helping to offer more support and monitoring in that situation. Nurse practitioner
. . .we had a really good team approach. . . We made sure, postpartum, to touch base with the care team that delivered and
the nurses, in-patient, to make sure they knew no formula, no formula, no formula. Nurse
Have a long history of undetectable viral load, certainly throughout pregnancy, but beyond that, probably even knowing that
they would have ongoing insurance coverage for the mom to be able to still maintain their medication. OB RN
I would want to keep her in our multidisciplinary perinatal clinic as long as she was breastfeeding. . . so she can continue to
benefit from those resources and make sure that we’re doing all the things we did during pregnancy to keep her viral loads sup-
pressed. Obstetrician
Category 4: Providers anticipating multilayered patient stigmatization
If you’re American born, you have been cultured for the most part that breastfeeding is an option. And if you don’t choose it,
you’re not choosing it for a bunch of reasons. Where my African born or Caribbean born women, if you don’t breastfeed. . . it’s
because you have HIV. Like one equals the other. Unspecified provider
I usually try to suggest some things that they could say to why they’re not [breastfeeding], so you’re on blood pressure medica-
tion, or you’re on diabetes medicine, or things like that to help. Nurse practitioner
HIV is stigmatizing, and you see everywhere, if you have any access to any form of media, that breast is best, breast is best. . .
It’s like you hear it in your head, and then you have these women who are told, ‘Your body actually isn’t best.’ So, that’s even
further stigmatizing. . . Nurse
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encounter the insecurity of formula feeding abroad, while
those who planned to remain within an immigrant community
might face pressures to breastfeed when among family,
friends and housemates.
4.6 | Category 4: Providers anticipating
multilayered patient stigmatization
A final category highlights providers’ awareness of the multi-
ple, intersecting layers of stigma facing pregnant and post-par-
tum WLHIV. This included both the association of formula
feeding with HIV in some communities, which could lead to
unwanted disclosure and HIV-related stigmatization, and the
stigmatization of formula feeding in environments where
breastfeeding has become the social norm. In the former case,
some providers attempted to support WLHIV to formula feed
by suggesting an alternative narrative. This strategy was most
commonly used among immigrants from cultures where
breastfeeding was the cultural norm and formula feeding was
interpreted as a sign of HIV. In the latter case, the recent
push in many U.S. institutions to promote breastfeeding has
contributed additional stigma among WLHIV who are formula
feeding their child. One provider channelled how these multi-
ple layers of stigma became internalized by patients: “Well, I
already feel like a bad person because I have HIV. Now I feel
like a bad person because I have HIV and I’m pregnant. And
now a really bad person because I can’t breastfeed my baby.”
5 | DISCUSSION
Using multiple methods of inquiry, we contextualized the
infant feeding environment as experienced by providers’ per-
spectives from caring for WLHIV or their infants in the U.S.
Reducing harm
“…the main concern would be that a mother would choose to do this and not feel like she could 
talk to her provider about it so, then, there’d be no way of actually helping to offer more support
and monitoring in that situation.”
“I have to get buy-in also from the other physicians who would be in the coverage pool so 
they’re not shocked and horrified…” 
Addressing reluctance
& controversy within 
care team
“…we had a really good team approach. So, I was involved. OB was involved. The Pediatric ID
team was involved. We made sure, postpartum, to touch base with the care team that delivered 
and the nurses, in-patient, to make sure they knew no formula, no formula, no formula.”
“One patient is one thing, but if it was many patients through different hospital systems, that
would be a bigger challenge logistically...”
Ensuring ongoing viral
suppression 
“I’d want to make sure that they met with peds ID, just knowing that this is what the care plan 
is going to entail.“
“I make sure the pediatricians are on board with this, because they become even more militant
about this, where they’ll say, ‘No. We’re going to call CPS.’“
“I would want to keep her in our multidisciplinary perinatal clinic as long as she was breastfeeding, 
and we have an excellent case management system and caseworkers who help each patient in the
community… so she can continue to benefit from those resources and make sure that we're doing all
the things we did during pregnancy to keep her viral loads suppressed.”
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“…[if] she was going to breastfeed … I needed to educate labor and delivery and inpatient
nurses and probably home visiting, you know: ‘Yep, we know about this and this is what the
plan is.’”
Coordinating care
“…in the US, yeah, we’d prefer you be formula feeding. However, if you’re not going to, then at
least do it with the lowest risk to you and your baby.”
“…there are oftentimes circumstances or particular kind of values of women that really make
them inclined to breastfeeding; and …it’s important for me and for physicians to kind of meet
them where they are to try to find ways to kind reduce risk and maximize the health of the
mother and the baby in that process.”
“Everybody knows and so we outline the infant feeding plan but knowing that it’s very 
controversial. …In the past, it’s been a Child Protective Services referral.”
“…if this is something you are strongly wanting to do, one, [we]  want to see you with a
consistently undetectable viral load before you deliver. So that’s to me, sort of a deal breaker.”
“Six weeks after you deliver, if you have Medicaid or emergency Medicaid, you lose your 
Medicaid. Then, you know what happens? You lose your medicine.”
“I think all of them have to be on the same page because it would be very dangerous if I come
up with an agenda that is opposite of that of the OB and the pediatrician. … I think that there
needs to be consensus among the group.”
“…if she's going to do it anyway then I practice harm reduction model and would need to do 
what we can do to reduce the risk of transmission even if she is not following our 
recommendations.”
“Have a long history of undetectable viral load, certainly throughout pregnancy, but beyond 
that, probably even knowing that they would have ongoing insurance coverage for the mom to 
be able to still maintain their medication.”
Figure 1. Dendogram of category 3: Harm Reduction Approaches to Supporting women living with HIV (WLHIV) in Breastfeeding.
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The majority of provider respondents had a WLHIV at their
practice ask if she could breastfeed, and a third reported that
a WLHIV breastfed despite the recommendation to formula
feed. We found that providers recognized that their patients
faced complex infant feeding situations, and they expressed
concern that the current formula-only guidelines did not serve
the full range of their clinical needs. Our study was conducted
prior to the recent update of the U.S. Perinatal Guidelines [3],
and thus reflected the dilemma providers faced at the time of
the interview. Despite this, providers described the range of
harm reduction strategies they undertook to manage complex
infant feeding situations. Several providers encountered
patients who resisted the recommendation due to personal
priorities and/or social barriers that the guidelines did not
address. They described their concerns about facilitating
adherence to current guidelines in the light of patients’ experi-
ences of multiple, compounding layers of stigmatization associ-
ated with formula feeding and HIV, and the potential for
unwanted disclosure of HIV status due to formula feeding.
Providers’ desire to respect mothers’ autonomy further com-
plicated their ability to adhere to a zero-breastfeeding guide-
line. In response to their patients’ needs, many providers
adopted a harm reduction philosophy stressing formula feed-
ing as the best practice while acknowledging that some
patients could not, or would not, follow it. Others continued
to follow the guidelines to the letter, with varying levels of
patient and provider satisfaction.
Previous findings from Canada, the United Kingdom and
the U.S. indicate that conflicting global guidelines and patients’
and providers’ awareness of research on HIV transmission
with ART has contributed to concerns about recommenda-
tions against breastfeeding. Our study is the first in the U.S.
to voice providers’ perspectives and explore their current
experiences on WLHIV breastfeeding. Migration both to and
from the U.S. presented the most acute challenges for many
providers and their patients. While providers shared that
some patients expressed opposition to formula feeding on the
basis that they perceived breastfeeding as superior to formula
feeding in terms of nutrition and/or bonding, providers more
frequently attributed patient resistance to situations in which
a combination of women’s culture, precarious legal status and
disclosure danger made formula feeding a risky choice for
them. Clinical guidelines must consider obstacles to formula
feeding among women who migrate from low-resource to
high-resource countries. While providers are primarily con-
cerned about cultural barriers to formula feeding in immigrant
communities, immigrant WLHIV also face numerous structural
challenges, including uncertainties in U.S. immigration policy
and ineligibility and/or lack of access to affordable medical
care and public benefits such as WIC. Moreover, women may
return to their home countries and therefore may be unable
to adhere to U.S. guidelines. These issues may continue to
present challenges for providers despite the update in U.S.
Perinatal Guidelines [3].
The survey revealed that 70% of provider respondents were
concerned about post-partum ART adherence, although this
emerged only as a secondary finding in the semi-structured
interviews. Several retrospective cohort U.S. studies demon-
strate poor post-partum retention in care and viral suppression
[28-30], which represents real-world scenarios in contrast to
the highly supported and well-resourced breastfeeding clinical
trials. The WHO acknowledges this concern and advises skilled
counselling and adherence support for post-partum women
[14]. In settings where guidelines recommend exclusively
breastfeeding for six months and continued breastfeeding up to
twenty-four months with ongoing maternal and infant ART use,
the WHO states health authorities should actively coordinate
and implement services in health facilities and activities in
workplaces, communities and homes to protect, promote and
support breastfeeding among WLHIV. Much of this has been
initiated in prevention of mother to child transmission clinic ser-
vices. However, operationalizing this statement in the U.S. may
pose challenging given suboptimal engagement in care post-par-
tum among all U.S. women [31].
5.1 | Limitations
This study aimed to gain insight into providers’ attitudes of
infant feeding caring for pregnant and post-partum WLHIV,
but the small survey sample limited statistical power and
made it difficult to assess associations. Therefore, we were
only able to present descriptive data. Additionally, the sample
overrepresented academic providers and unevenly repre-
sented the variety of clinical roles, which might have led to
selection bias. Despite these limitations, we were able to cap-
ture a broad range of providers’ perspectives from across the
country. Furthermore, the richness of qualitative responses
from the subset of interviewees highlighted the complexities
and nuances that were less evident from the structured sur-
vey. Future research that explores both provider and patient
experiences qualitatively from participants across the country
may provide more insight.
5.2 | Clinical and public health implications
Providers’ experiences indicate that their pregnant and post-
partum WLHIV patients in the U.S. face a range of complex
infant feeding realities and that current guidelines did not
meet many of their patients’ needs. These findings are consis-
tent with Waitt et al.’s viewpoint piece that thoroughly outlined
the biomedical evidence and important gaps in our knowledge
of optimal clinical care to support a WLHIV with breastfeeding
[32]. The tension between current recommendations to avoid
breastfeeding and patient desires may continue to inhibit the
patient-provider relationship, which many providers fear may
lead some WLHIV to engage in riskier infant feeding beha-
viours. For instance, some WLHIV may decide to breastfeed
in secret rather than oppose provider recommendations
directly. This may continue despite the update to Perinatal
Guidelines and may need to be explored further. Whether
these guidelines change the clinical course given the main
message remains the same is uncertain.
6 | CONCLUSIONS
Our study explored providers’ current perspectives and expe-
riences around infant feeding among pregnant and post-par-
tum WLHIV. Our findings provide important insight to inform
professional organizations discussions about public health pol-
icy as they consider future directions for infant feeding guide-
lines among WLHIV. Ultimately, when considering best
Tuthill EL et al. Journal of the International AIDS Society 2019, 22:e25224
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25224/full | https://doi.org/10.1002/jia2.25224
8
practices for supporting WLHIV, accounting for the role of
how gender, race, culture and HIV-related stigma intersect
with motherhood and infant feeding is paramount.
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